FIM
IBB icon

Fernwood Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Fernwood Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$388K Sell
2,933
-490
-14% -$68.9K 0.13% 122
2024
Q3 		$498K Sell
3,423
-423
-11% -$61.2K 0.16% 122
2024
Q2 		$528K Sell
3,846
-25
-0.6% -$3.34K 0.16% 118
2024
Q1 		$531K Sell
3,871
-2
-0.1% -$273 0.15% 124
2023
Q4 		$526K Sell
3,873
-346
-8% -$42.2K 0.17% 116
2023
Q3 		$516K Sell
4,219
-4
-0.1% -$509 0.19% 114
2023
Q2 		$536K Sell
4,223
-303
-7% -$39.4K 0.19% 112
2023
Q1 		$585K Sell
4,526
-150
-3% -$19.6K 0.22% 103
2022
Q4 		$614K Buy
4,676
+150
+3% +$19.4K 0.25% 104
2022
Q3 		$529K Sell
4,526
-150
-3% -$18.6K 0.22% 110
2022
Q2 		$550K Sell
4,676
-50
-1% -$5.93K 0.24% 110
2022
Q1 		$616K Sell
4,726
-250
-5% -$32.6K 0.22% 116
2021
Q4 		$759K Sell
4,976
-100
-2% -$15.5K 0.25% 106
2021
Q3 		$821K Sell
5,076
-5
-0.1% -$841 0.28% 99
2021
Q2 		$832K Hold
5,081
– – 0.28% 98
2021
Q1 		$765K Buy
5,081
+305
+6% +$48.4K 0.28% 98
2020
Q4 		$724K Hold
4,776
– – 0.29% 96
2020
Q3 		$647K Sell
4,776
-700
-13% -$95K 0.31% 90
2020
Q2 		$749K Hold
5,476
– – 0.37% 82
2020
Q1 		$590K Sell
5,476
-540
-9% -$62.2K 0.38% 79
2019
Q4 		$725K Sell
6,016
-125
-2% -$13.9K 0.35% 75
2019
Q3 		$611K Sell
6,141
-205
-3% -$21.5K 0.3% 89
2019
Q2 		$692K Sell
6,346
-500
-7% -$53.2K 0.38% 68
2019
Q1 		$765K Sell
6,846
-240
-3% -$26.3K 0.41% 65
2018
Q4 		$683K Sell
7,086
-505
-7% -$53.6K 0.44% 67
2018
Q3 		$926K Buy
7,591
+200
+3% +$23.6K 0.49% 58
2018
Q2 		$812K Sell
7,391
-250
-3% -$26.7K 0.44% 66
2018
Q1 		$816K Buy
7,641
+150
+2% +$16.6K 0.46% 59
2017
Q4 		$800K Buy
7,491
+1,170
+19% +$125K 0.43% 64
2017
Q3 		$703K Buy
+6,321
New +$676K 0.44% 60

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fernwood Investment Management's IBB Position: Q4 2024 in Review

Fernwood Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 14% in Q4 2024, selling an estimated $68.9K and leaving 2,933 shares worth $388K. The position accounts for 0.13% of the portfolio, ranked #122.

Fernwood Investment Management first reported a position in IBB in Q3 2017 and has held it in 30 quarters since. The position peaked at $926K in Q3 2018. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Fernwood Investment Management held 2,933 shares of iShares Biotechnology ETF worth $388K as of Q4 2024.
  • Fernwood Investment Management sold 490 iShares Biotechnology ETF shares in Q4 2024, an estimated $68.9K.
  • iShares Biotechnology ETF made up 0.13% of Fernwood Investment Management's portfolio in Q4 2024, its #122 holding.
  • Fernwood Investment Management first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 30 quarters since.
  • Fernwood Investment Management's iShares Biotechnology ETF position peaked at $926K in Q3 2018.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.